| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA3536572 | ADME | Drug metabolism assessed as human recombinant FMO5-mediated ER-879123 formation at 10 uM after 60 mins by LC-MS/MS method in presence of NADPH | Homo sapiens | 1 | ALA3525952 | single protein format | Scientific Literature | |
| 2. | ALA3536573 | ADME | Drug metabolism assessed as human recombinant FMO5-mediated ER-879123 formation in presence NADH at 10 uM after 60 mins by LC-MS/MS method | Homo sapiens | 1 | ALA3525952 | single protein format | Scientific Literature | |
| 3. | ALA3531399 | ADME | Drug level assessed as human recombinant FMO5-mediated compound formation from 10 uM ER-879819 in presence NADPH after 60 mins by LC-MS/MS method | Homo sapiens | 1 | ALA3525952 | single protein format | Scientific Literature | |
| 4. | ALA3531400 | ADME | Drug level assessed as human recombinant FMO5-mediated compound formation from 10 uM ER-879819 in presence NADH after 60 mins by LC-MS/MS method | Homo sapiens | 1 | ALA3525952 | single protein format | Scientific Literature | |
| 5. | ALA3531516 | ADME | Drug metabolism assessed as human recombinant FMO5-mediated ER-879123 formation in presence of rat liver cytosolic fractions at 50 uM after 60 mins by LC-MS/MS method | Homo sapiens | 1 | ALA3525952 | tissue-based format | Scientific Literature | |
| 6. | ALA3531517 | ADME | Drug metabolism assessed as human recombinant FMO5-mediated ER-879123 formation in presence of dog liver cytosolic fractions at 50 uM after 60 mins by LC-MS/MS method | Homo sapiens | 1 | ALA3525952 | tissue-based format | Scientific Literature | |
| 7. | ALA3531518 | ADME | Drug metabolism assessed as human recombinant FMO5-mediated ER-879123 formation in presence of human liver cytosolic fractions at 50 uM after 60 mins by LC-MS/MS method | Homo sapiens | 1 | ALA3525952 | tissue-based format | Scientific Literature | |
| 8. | ALA3531519 | ADME | Drug metabolism assessed as human recombinant FMO5-mediated compound formation from 50 uM E7016 in presence of rat liver cytosolic fractions after 60 mins by LC-MS/MS method | Homo sapiens | 1 | ALA3525952 | tissue-based format | Scientific Literature | |
| 9. | ALA3531520 | ADME | Drug metabolism assessed as human recombinant FMO5-mediated compound formation from 50 uM E7016 in presence of human liver cytosolic fractions after 60 mins by LC-MS/MS method | Homo sapiens | 1 | ALA3525952 | tissue-based format | Scientific Literature | |
| 10. | ALA3531521 | ADME | Drug metabolism assessed as human recombinant FMO5-mediated compound formation from 50 uM E7016 in presence of dog liver cytosolic fractions after 60 mins by LC-MS/MS method | Homo sapiens | 1 | ALA3525952 | tissue-based format | Scientific Literature | |
| 11. | ALA3531522 | ADME | Drug metabolism assessed as human recombinant FMO5-mediated ER-879123 formation in absence of rat liver cytosolic fractions at 50 uM after 60 mins by LC-MS/MS method | Homo sapiens | 1 | ALA3525952 | tissue-based format | Scientific Literature | |
| 12. | ALA3531523 | ADME | Drug metabolism assessed as human recombinant FMO5-mediated ER-879123 formation in absence of dog liver cytosolic fractions at 50 uM after 60 mins by LC-MS/MS method | Homo sapiens | 1 | ALA3525952 | tissue-based format | Scientific Literature | |
| 13. | ALA3531524 | ADME | Drug metabolism assessed as human recombinant FMO5-mediated ER-879123 formation in absence of human liver cytosolic fractions at 50 uM after 60 mins by LC-MS/MS method | Homo sapiens | 1 | ALA3525952 | tissue-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!